We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 40.50 | 40.00 | 41.00 | 40.50 | 40.50 | 40.50 | 38,613 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 98.78 | 50.96M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/2/2017 08:28 | When in doubt, don't. Dacian. Folks have done well on PVG. Well done to them. I take the view that some bandwagons charge forward then stop and that it is easy to jump on board when they have stopped. I think I'm saying that I agree with you, except that it is not on my watch list. I think I'm getting too attracted to roulette wheel shares. SOU and FARN are flattering me. It's the attraction of finding rocket ships rather than bandwagons! Go BVXP - I keep wondering if the sheep antibodies (strange they come from immortal cancer cells) can deliver reliable positive and negative results. Pure speculation based on zero knowledge. I keep looking at FREE - need a cold shower. Have a good w'end y'all. apad ps Found an erudite article on Book Value and solved my problem by retitling my spreadsheet cell as Book Cost! Doh. | apad | |
04/2/2017 08:12 | Dacian You have obviously evaluated the risks involved in PVG and appear to have a good understanding of the business model. Your conviction remains the final hurdle: To buy, or not to buy, that is the question.... I see the attractions, but the weighting towards the high risk end of the scale would be too great for me. It is a one trick poodle that may or may not add real value to it's customers. Just MHO red | redartbmud | |
04/2/2017 08:12 | IC on PRV Porvair delivers With the bulk of its contracts secured abroad, Porvair’s (PRV) revenue streams were swollen by sterling’s post-referendum decline in 2016. But even devoid of translation benefits, the specialist filtration group’s top line was 8 per cent to the good, driven by a particularly strong showing from its microfiltration division. Operating profits of £10.7m were 9 per cent in advance of its 2015 year-end. Over the past few years, the group has moved out of the red into a net cash position, while substantially building capacity and expanding its geographic footprint. The proliferation of large-scale gas projects in Asia continues to drive commercial opportunities in microfiltration. Aviation revenues, up 21 per cent through the year, provide another pointer to growth opportunities, with new orders coming through for industry programmes, including the Airbus A350, Boeing 777X and Bombardier C Series. Management was also encouraged by the order pipeline for the nuclear and bioscience filtration segments. Peel Hunt upgraded its adjusted pre-tax and EPS forecasts for the November 2017 year-end from £10.3m and 17.4p to £10.6m and 18p, respectively, and from £10.5m and 17.7p to £11m and 18.6p, respectively, in 2018 (from £10.1m and 17.1p in 2016). The nation’s move away from coal-fired generation now represents a long-term structural driver. The TEM filters subsidiary has bedded in well since its acquisition in December 2015, greatly enhancing the group’s offering in microelectronics filtration. The shares are priced for growth at 25 times forecast earnings. | apad | |
04/2/2017 08:11 | IC on RSW Renishaw’s profits come with price tag Renishaw (RSW) justified its lofty rating at the halfway mark, driving profits and cash flows on the back of another strong showing from its core metrology (measurement) business, where operating profits were up by a third. Group earnings benefited from a reclassification of a tax credit, but gross profits of £115m were 23 per cent in advance of the previous comparable figure. Before investment outflows, operating cash flows all but quadrupled to £51.3m, although the precision engineer still increased its investment in research and development by 15 per cent. That’s hardly surprising given Renishaw supplies products and services at the high end of the value chain across a range of industrial segments. Trading was encouraged by continued strong demand for encoder and laser calibration products within the metrology business. And although sales pulled back slightly at the smaller healthcare business, there are still strong prospects for new products. There was progress across the group’s locales, with Europe and the Americas both registering double-digit revenue growth. Renishaw’s markets in the Far East – its largest revenue segment – provided the standout performance, with revenues up 27 per cent, including a significant currency translation benefit. Consensus forecasts from data service IBES give EPS of 109p for the June 2017 yearend, up from 94.9p in FY2016. We maintain our hold call on Renishaw’s shares. Its long-term growth potential is adequately reflected in a forward rating of 27 times forecast earnings, particularly given prevailing political uncertainties. | apad | |
03/2/2017 14:53 | Glassdoor on FreeAgent. apad FreeAgent Logo "Awesome place to work" StarStarStarStarStar Current Employee - Anonymous Employee Recommends Positive Outlook Pros I'm convinced that I'll never work at a better company than FreeAgent - it really is an awesome place to come every day. *The execs are all very approachable and transparent about the company's direction and any issues or opportunities that they're considering * Everyone here is very, very smart and very, very nice. * You're treated like an adult here - you're trusted to get on with your work but you also have the support of your team * Regular hack days and social events, and catered team lunches every Friday * A great-looking office with amazing views of Edinburgh Show Less Cons I honestly can't think of any real downsides to working here. FreeAgent is growing quickly and there are of course growing pains as we scale, but any issues that pop up are always handled with a lot of thought and compassion by the exec team. Advice to Management Just keep doing what you're doing! | apad | |
03/2/2017 09:10 | APAD - 22 Dec 2016 - 21:38:43 - 7495 of 8158 ValueGrowth Investing - VLG HLMA and ABC approaching Buy on the Dip territory. apad | apad | |
03/2/2017 08:43 | upgrade I believe HLMA Halma PLC HLMA Barclays Capital Overweight 922.00 926.00 1,070.00 1,150.00 Upgrades - also KWS initiation 760p target is one I follow - Berenberg I believe but not seen it generally out | felix99 | |
03/2/2017 08:37 | HLMA - classic buy the dip opportunity, m. Down 20% back end of last year - good company. apad | apad | |
03/2/2017 08:32 | SPE - tipped to double in shares magazine. PRSM looking very sad - sold after scotts critique of it - but wish I had put all the proceeds in spe! | janeann | |
03/2/2017 08:13 | HLMA - Good start to the day (+6%). Can't see any news out there, but someone's keen this morning. | madmix | |
03/2/2017 07:25 | Clarification - mod. Buying the dips is not bottom fishing. I do not buy companies dealing with trouble. Good companies have dips. RDSB and WEIR had severe dips that were obvious buying opportunities that I identified easily. I did not act on WEIR because I had already been buying smaller dips and was overexposed to O&G engineering suppliers. Also I was building up stakes in some AIM companies. I could have timed WEIR better, but buying the dips is not bottom fishing it is a sensible way of growing a holding. My WEIR shares are at a 20% premium and yield 2.6%. apad ps The more I practise the luckier I get. pps Buying the dips is not bottom fishing | apad | |
02/2/2017 21:57 | PS The Vanl ship has sailed away for now. I was too slow as I would have taken 108p, but somehow too mean to pay 109.4p Everything has it's price, and I often seem to get it wrong in some degree. He/she who consistently sells at the top and buys at the bottom is only using Monopoly money, not the real thing. (And not real shares!). red | redartbmud | |
02/2/2017 21:51 | mod I understand where you are coming from and agree to a degree. I have always tried to look for dips, for which there has been no explanation, in shares where I have believed the weakness to be short lived. It has only been the odd one where I have come unstuck. Carillion happens to be the odd one in this example although I admit that I have tended to ignore the effect of the Hedgies. It has always been my belief that their effect has not been permanent when the share price has fallen significantly in a short space of time. I must have traded them at least 15 - 20 times before, so the odds against me maintaining total success must increase with every trade. I have traded Rsw 20 times in my Sipp, since mid 2011 and done ok so far. I have paid more than lip service to most of the items that you have quoted, but not always with the weighting that they probably deserve. My modest girth has been put to use quite effectively. I agree on the subject of effective bottom fishing. A few years ago, I bought a year's subscription to a US system, Vector Vest. No doubt some people have made money on their 'easy' trading picks. Some of them worked for me, but the golden goose at the end of the rainbow was a myth, despite the power of their programmes, written by guys and gals who are obviously far more clever than little old me. I note that Mercian is having a placing, a party to which I am not invited. It will be a case of waiting for a dip to counteract the effects of dilution. red | redartbmud | |
02/2/2017 19:05 | Apad, I am afraid I have to utterly disagree with you there. First of all, let's distinguish that there's a difference between trading and investing. Red was trading with the purchase of C, and in my experience you never trade based on fundamentals, you always trade based on, momentum, chart, breakout, increased volume, trading update, blah blah. Yesterday AMD produced its results which was better than expected, now the sentiment had changed, so you could have bought in the first hour and by now, you could have made 15%. On investment side, how did you get RDSB at the bottom last January, pure luck apad. I recall you got WEIR at £15, and it bottomed at around £8. So bottom fishing based on fundamentals is incredibly hard, as none knows where the bottom is. We all trade and invest differently and as long as it works for you, don't change it. Peter, any metal miners will have a bullish chart, AAL VED FXPO KAZ, and KAZ has the most bullish chart and rose today even with Cu being off. | modform | |
02/2/2017 16:54 | APAD That is one of the interesting phenomena of markets. You would expect that a share falls by approximately the amount of the dividend on the day that it goes ex. In subsequent days, the share price recovers, subject to general market trends. Sometimes the share price substantially recovers on the day. It is not a precise science. A few days ago, I bought SSE on xd for that very reason. Having paid £15.12 I have watched the price fall to £14.82, despite a reaffirmation that dividend growth will at least match RPI for the next two years. It fell 50 odd pence, and the dividend was 27.4p I said that I would be happy to hold, if my timing was wrong. This is the first time, so far, that my strategy has failed me when I have tried this little exercise. It will come right sooner or later as the next xd in July is 62.5p. I can wait. red | redartbmud | |
02/2/2017 14:11 | IGG down on ex div first thing, now back up again! apad | apad | |
02/2/2017 13:09 | Strongly disagree, mod. It's not about fighting, it's about backing your own judgement. The market is often wrong, even about large company shares that are well tintined. I have a 61% gain and a 10% yield in RDSB in a year. Spotting markets getting it wrong can be very lucrative. I still think CLLN's out of favour status is odd, but I got bored and pocketed a bit of a profit. Pet companies. Interesting, but not for me. Not sure why. Too late maybe? Not comfortable anyway. Still looking at FREE in the light of HMRC proposed changes and the amazing adulation of its customers. However, I have only been increasing my own shareholdings recently. So, never mind the rhetoric, look at the behaviour. apad | apad | |
02/2/2017 12:33 | Never fight the market red, much easier sometimes to ignore the fundamentals and follow the smart money | modform | |
02/2/2017 11:42 | Unloved in the market. What else can one say. red | redartbmud | |
02/2/2017 11:26 | CLLN even down on the day after such a positive (surely?) RNS. Really is under the thumb by the looks of things! | lauders | |
02/2/2017 10:01 | Blimey, a short lived spike from CLLN, red. The short overhang must be weighing against any long-term trend I guess. I'm surprised how long these things go on for. apad | apad | |
02/2/2017 08:32 | PS Clln share £900m red | redartbmud |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions